Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | NOL6 | Human | (+)-schisandrin B | multiple interactions | ISO | Nol6 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NOL6 mRNA] | CTD | PMID:31150632 | NOL6 | Human | 1,2-dimethylhydrazine | increases expression | ISO | Nol6 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of NOL6 mRNA | CTD | PMID:22206623 | NOL6 | Human | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of NOL6 mRNA | CTD | PMID:23019147 and PMID:31614463 | NOL6 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Nol6 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of NOL6 mRNA | CTD | PMID:21570461 | NOL6 | Human | 2-methylcholine | affects expression | EXP | | 6480464 | beta-methylcholine affects the expression of NOL6 mRNA | CTD | PMID:21179406 | NOL6 | Human | 2-palmitoylglycerol | increases expression | EXP | | 6480464 | 2-palmitoylglycerol results in increased expression of NOL6 mRNA | CTD | PMID:37199045 | NOL6 | Human | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of NOL6 mRNA | CTD | PMID:28628672 | NOL6 | Human | 4,4'-sulfonyldiphenol | affects expression | EXP | | 6480464 | bisphenol S affects the expression of NOL6 protein | CTD | PMID:31945527 | NOL6 | Human | acrolein | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NOL6 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of NOL6 mRNA | CTD | PMID:32699268 | NOL6 | Human | aldehydo-D-glucose | multiple interactions | ISO | Nol6 (Rattus norvegicus) | 6480464 | NOL6 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] | CTD | PMID:21124846 | NOL6 | Human | alpha-pinene | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NOL6 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of NOL6 mRNA | CTD | PMID:32699268 | NOL6 | Human | amiodarone | increases expression | EXP | | 6480464 | Amiodarone results in increased expression of NOL6 mRNA | CTD | PMID:19774075 | NOL6 | Human | amphetamine | decreases expression | ISO | Nol6 (Rattus norvegicus) | 6480464 | Amphetamine results in decreased expression of NOL6 mRNA | CTD | PMID:30779732 | NOL6 | Human | arsenous acid | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of NOL6 mRNA | CTD | PMID:20458559 | NOL6 | Human | atrazine | decreases expression | EXP | | 6480464 | Atrazine results in decreased expression of NOL6 mRNA | CTD | PMID:22378314 | NOL6 | Human | benzo[a]pyrene | multiple interactions | ISO | Nol6 (Mus musculus) | 6480464 | Benzo(a)pyrene promotes the reaction [AHR protein binds to NOL6 promoter] | CTD | PMID:19654925 | NOL6 | Human | bisphenol A | decreases expression | ISO | Nol6 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of NOL6 mRNA | CTD | PMID:25181051 | NOL6 | Human | bisphenol A | increases expression | ISO | Nol6 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of NOL6 mRNA | CTD | PMID:30816183 | NOL6 | Human | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of NOL6 mRNA and bisphenol A results in decreased expression of NOL6 protein | CTD | PMID:29275510 more ... | NOL6 | Human | bisphenol F | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of NOL6 mRNA | CTD | PMID:28628672 | NOL6 | Human | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of NOL6 mRNA | CTD | PMID:27594783 | NOL6 | Human | clofibric acid | multiple interactions | ISO | Nol6 (Rattus norvegicus) | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of NOL6 mRNA | CTD | PMID:17602206 | NOL6 | Human | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of NOL6 mRNA | CTD | PMID:19320972 | NOL6 | Human | D-glucose | multiple interactions | ISO | Nol6 (Rattus norvegicus) | 6480464 | NOL6 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] | CTD | PMID:21124846 | NOL6 | Human | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of NOL6 mRNA | CTD | PMID:28628672 | NOL6 | Human | diarsenic trioxide | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of NOL6 mRNA | CTD | PMID:20458559 | NOL6 | Human | dicrotophos | increases expression | EXP | | 6480464 | dicrotophos results in increased expression of NOL6 mRNA | CTD | PMID:28302478 | NOL6 | Human | dioxygen | multiple interactions | ISO | Nol6 (Rattus norvegicus) | 6480464 | NOL6 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] | CTD | PMID:21124846 | NOL6 | Human | endosulfan | increases expression | ISO | Nol6 (Rattus norvegicus) | 6480464 | Endosulfan results in increased expression of NOL6 mRNA | CTD | PMID:29391264 | NOL6 | Human | enzyme inhibitor | multiple interactions | EXP | | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of NOL6 protein | CTD | PMID:23301498 | NOL6 | Human | epoxiconazole | decreases expression | ISO | Nol6 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of NOL6 mRNA | CTD | PMID:35436446 | NOL6 | Human | ethanol | decreases expression | ISO | Nol6 (Mus musculus) | 6480464 | Ethanol results in decreased expression of NOL6 mRNA | CTD | PMID:29018328 | NOL6 | Human | ethanol | affects splicing | ISO | Nol6 (Mus musculus) | 6480464 | Ethanol affects the splicing of NOL6 mRNA | CTD | PMID:30319688 | NOL6 | Human | ethyl methanesulfonate | decreases expression | EXP | | 6480464 | Ethyl Methanesulfonate results in decreased expression of NOL6 mRNA | CTD | PMID:23649840 | NOL6 | Human | fenthion | increases expression | ISO | Nol6 (Mus musculus) | 6480464 | Fenthion results in increased expression of NOL6 mRNA | CTD | PMID:34813904 | NOL6 | Human | flutamide | increases expression | ISO | Nol6 (Rattus norvegicus) | 6480464 | Flutamide results in increased expression of NOL6 mRNA | CTD | PMID:24136188 | NOL6 | Human | flutamide | decreases expression | ISO | Nol6 (Rattus norvegicus) | 6480464 | Flutamide results in decreased expression of NOL6 mRNA | CTD | PMID:24793618 | NOL6 | Human | genistein | increases expression | EXP | | 6480464 | Genistein results in increased expression of NOL6 mRNA | CTD | PMID:23019147 | NOL6 | Human | glucose | multiple interactions | ISO | Nol6 (Rattus norvegicus) | 6480464 | NOL6 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] | CTD | PMID:21124846 | NOL6 | Human | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of NOL6 mRNA | CTD | PMID:28628672 | NOL6 | Human | isobutanol | multiple interactions | EXP | | 6480464 | [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of NOL6 mRNA | CTD | PMID:29432896 | NOL6 | Human | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of NOL6 protein | CTD | PMID:32959892 | NOL6 | Human | manganese(II) chloride | increases expression | ISO | Nol6 (Rattus norvegicus) | 6480464 | manganese chloride results in increased expression of NOL6 mRNA | CTD | PMID:28801915 | NOL6 | Human | methidathion | increases expression | ISO | Nol6 (Mus musculus) | 6480464 | methidathion results in increased expression of NOL6 mRNA | CTD | PMID:34813904 | NOL6 | Human | methotrexate | affects expression | ISO | Nol6 (Mus musculus) | 6480464 | Methotrexate affects the expression of NOL6 mRNA | CTD | PMID:18502557 | NOL6 | Human | methoxychlor | affects methylation | ISO | Nol6 (Rattus norvegicus) | 6480464 | Methoxychlor affects the methylation of NOL6 gene | CTD | PMID:35440735 | NOL6 | Human | methyl methanesulfonate | decreases expression | EXP | | 6480464 | Methyl Methanesulfonate results in decreased expression of NOL6 mRNA | CTD | PMID:23649840 | NOL6 | Human | N-nitrosodiethylamine | multiple interactions | ISO | Nol6 (Rattus norvegicus) | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of NOL6 mRNA | CTD | PMID:17602206 | NOL6 | Human | nickel atom | increases expression | EXP | | 6480464 | Nickel results in increased expression of NOL6 mRNA | CTD | PMID:24768652 and PMID:25583101 | NOL6 | Human | ozone | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NOL6 mRNA more ... | CTD | PMID:32699268 | NOL6 | Human | paracetamol | affects expression | ISO | Nol6 (Mus musculus) | 6480464 | Acetaminophen affects the expression of NOL6 mRNA | CTD | PMID:17562736 | NOL6 | Human | perfluorohexanesulfonic acid | decreases expression | ISO | Nol6 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in decreased expression of NOL6 mRNA | CTD | PMID:37995155 | NOL6 | Human | perfluorononanoic acid | increases expression | EXP | | 6480464 | perfluoro-n-nonanoic acid results in increased expression of NOL6 mRNA | CTD | PMID:32588087 | NOL6 | Human | perfluorononanoic acid | decreases expression | EXP | | 6480464 | perfluoro-n-nonanoic acid results in decreased expression of NOL6 mRNA | CTD | PMID:25812627 | NOL6 | Human | perfluorooctane-1-sulfonic acid | decreases expression | ISO | Nol6 (Mus musculus) | 6480464 | perfluorooctane sulfonic acid results in decreased expression of NOL6 protein | CTD | PMID:26178269 | NOL6 | Human | perfluorooctane-1-sulfonic acid | decreases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in decreased expression of NOL6 mRNA | CTD | PMID:25812627 | NOL6 | Human | perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of NOL6 mRNA | CTD | PMID:25812627 | NOL6 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of NOL6 protein | CTD | PMID:37664457 | NOL6 | Human | silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide results in increased expression of NOL6 mRNA | CTD | PMID:34973136 | NOL6 | Human | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of NOL6 mRNA | CTD | PMID:34032870 | NOL6 | Human | Soman | decreases expression | ISO | Nol6 (Rattus norvegicus) | 6480464 | Soman results in decreased expression of NOL6 mRNA | CTD | PMID:19281266 | NOL6 | Human | temozolomide | increases expression | EXP | | 6480464 | Temozolomide results in increased expression of NOL6 mRNA | CTD | PMID:31758290 | NOL6 | Human | tetrachloromethane | increases expression | ISO | Nol6 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in increased expression of NOL6 mRNA | CTD | PMID:31150632 | NOL6 | Human | tetrachloromethane | multiple interactions | ISO | Nol6 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NOL6 mRNA] | CTD | PMID:31150632 | NOL6 | Human | thioacetamide | increases expression | ISO | Nol6 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of NOL6 mRNA | CTD | PMID:23411599 and PMID:34492290 | NOL6 | Human | Triptolide | increases expression | ISO | Nol6 (Mus musculus) | 6480464 | triptolide results in increased expression of NOL6 mRNA | CTD | PMID:32835833 | NOL6 | Human | urethane | decreases expression | EXP | | 6480464 | Urethane results in decreased expression of NOL6 mRNA | CTD | PMID:28818685 | NOL6 | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of NOL6 mRNA | CTD | PMID:23179753 | NOL6 | Human | vinclozolin | affects expression | ISO | Nol6 (Rattus norvegicus) | 6480464 | vinclozolin affects the expression of NOL6 mRNA | CTD | PMID:19015723 | NOL6 | Human | vinclozolin | increases expression | ISO | Nol6 (Rattus norvegicus) | 6480464 | vinclozolin results in increased expression of NOL6 mRNA | CTD | PMID:23034163 | |